🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The MOBY Study: Efficacy of Birth Mobility

RecruitingNAAges 18 Years - anyFemaleVibwife AG
NCT07052331 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This randomized clinical trial investigates whether and how maternal mobility during labor influences birth outcomes in primiparous women. The study compares standard obstetric care with care that includes a birth mobility system. The primary aim is to assess whether the system helps reduce secondary cesarean section rates. Secondary objectives include evaluation of labor progression, medication use, newborn health, and user satisfaction. Participation occurs during birth and includes the collection of routine clinical data and a short questionnaire afterward.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years * German- or English-speaking * Able to provide written informed consent with capacity of judgment * Low-risk singleton pregnancy * Primiparous woman * Cephalic presentation * Gestational age at delivery ≥ 37 + 0 weeks Exclusion Criteria: * Multiparous woman * Not capable of understanding instructions for use of the mobility system (intervention group) * Scheduled (elective) cesarean section * Contraindication to vaginal delivery * Multiple pregnancy * Breech presentation * Estimated fetal weight \< 10th percentile or \> 90th percentile * Relevant fetal congenital abnormalities affecting neonatal adaptation * Pre-existing medical conditions significantly affecting mobility (e.g., orthopedic conditions, osteoporosis, multiple sclerosis, spinal cord injury) * Relevant intrapartum bleeding * Preeclampsia or HELLP syndrome
💊

What it tests

  • Birth Mobility System
📍

Where

1 site
Kantonsspital Baden
Baden, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy